SUVmax-IPI as a New Prognostic Index in Metastatic Non-Small Cell Lung Cancer Patients Receiving Nivolumab.

Curr Oncol · 2025 · PMC12564384 · PMID 41149486

Europe PMC DOI

hedged sentences

0.0480

closest p · 1.0× alpha

0.1750

boldest claim

The sentences

marginally significantp = 0.048actually significant

When compared to the IPI-alone model, the SUVmax-IPI model showed a marginally significant improvement in model fit (Δ−2LL = 3.91, p = 0.048).

also in 26,082 other papers

did not reach statistical significancep = 0.175not close (p > 0.1)

8 months), this did not reach statistical significance (log-rank p = 0.175).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.